Clinical Trial Update: Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis [NA]

View source ↗

Summary

A completed clinical trial from University Hospital, Bordeaux investigates the role of soluble CD95 ligand in the pathophysiology of ANCA-associated vasculitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: ANCA Associated Vasculitis | NA | Status: COMPLETED